2023 연구자 정보 (26 / 1128)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Chang, S-J. (Chang, SJ) |
Ajou Univ, Dept Obstet & Gynecol, Hosp Sch Med, Suwon, South Korea |
|
|
[JCR상위 1.1%] A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04) | SCIE | 1.1 | ONCOLOGY | |||
|
Cho, H. -J. (Cho, HJ) |
Daegu Fatima Hosp, Fatima Res Inst, Daegu, South Korea |
|
|
[JCR상위 1.1%] CHEMOKINE RECEPTOR CXCR7 CONTRIBUTE TO THE INFLAMMATORY REACTION OF ARTICULAR CHONDROCYTE | SCIE | 1.1 |
ORTHOPEDICS RHEUMATOLOGY |
|||
|
Cho, J. (Cho, J) |
Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea |
|
|
[JCR상위 1.1%] Enhancing lung nodule discrimination with a novel cfDNA test: The cancer signature ensemble (CSE) approach [JCR상위 9.6%] Patterns of recurrence, treatment, and outcome of lymph node recurrence after SBRT for lung cancer |
SCIE | 1.1 |
ONCOLOGY RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING |
|||
|
Choi, Sae-Kyoung (Choi, SK) |
Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Incheon, Kyonggi Do, South Korea |
|
|
[JCR상위 1.1%] Impacts of tocolytics on maternal and neonatal glucose levels in women with gestational diabetes mellitus | SCIE | 1.1 | OBSTETRICS & GYNECOLOGY | |||
|
Choi, Soo Ran (Choi, SR) |
Inha Univ Hosp, Incheon, South Korea |
|
|
[JCR상위 1.1%] Impacts of tocolytics on maternal and neonatal glucose levels in women with gestational diabetes mellitus | SCIE | 1.1 | OBSTETRICS & GYNECOLOGY | |||
|
Cortes, J. (Cortés, J) |
Int Breast Canc Ctr, Oncol, Pangaea Oncol, Quironsalud Grp, Madrid, Spain Int Breast Canc Ctr, Oncol, Pangaea Oncol, Quironsalud Grp, Barcelona, Spain |
|
|
[JCR상위 1.1%] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) | SCIE | 1.1 | ONCOLOGY | |||
|
Edeline, J. (Edeline, J) |
Ctr Eugene Marquis, Dept Med Oncol, Rennes, France |
|
|
[JCR상위 1.1%] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 | SCIE | 1.1 | ONCOLOGY | |||
|
Finn, R. S. (Finn, RS) |
제1저자 | Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Geffen Sch Med, Los Angeles, CA 90095 USA |
|
|
[JCR상위 1.1%] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 | SCIE | 1.1 | ONCOLOGY | ||
|
Furuse, J. (Furuse, J) |
Kanagawa Canc Ctr, Dept Gastroentel, Yokohama, Tokyo, Japan |
|
|
[JCR상위 1.1%] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 | SCIE | 1.1 | ONCOLOGY | |||
|
Gambhire, Dhiraj (Gambhire, D) |
Daiichi Sankyo Inc, Basking Ridge, NJ USA |
|
|
[JCR상위 1.1%] T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04 | SCIE | 1.1 | ONCOLOGY | |||
|
Halser-Strub, U. (Halser-Strub, U) |
Kantonsspital St Gallen, Breast Ctr, St Gallen, Switzerland |
|
|
[JCR상위 1.1%] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) | SCIE | 1.1 | ONCOLOGY | |||
|
Han, S. (Han, S) |
Kyungpook Natl Univ, Daegu, South Korea |
|
|
[JCR상위 1.1%] ENHANCING OXIDATIVE PHOSPHORYLATION THROUGH INHIBITION OF PDK2 ALLEVIATES CARTILAGE DEGRADATION IN A SURGICAL MODEL OF OSTEOARTHRITIS | SCIE | 1.1 |
ORTHOPEDICS RHEUMATOLOGY |
|||
|
He, Weidong (He, WD) |
Harbin Inst Technol, Ctr Composite Mat & Struct, Natl Key Lab Sci & Technol Adv Composites Special, Harbin 150080, Peoples R China |
F-5952-2010 He, Weidong |
|
[JCR상위 1.1%] Exploration of metal organic frameworks and covalent organic frameworks for energy-related applications | SCIE | 1.1 | CHEMISTRY, INORGANIC & NUCLEAR |
Jiabao.yi@newcastle.edu.au liang.qiao@uestc.edu.cn |
||
|
Hong, D. G. (Hong, DG) |
Kyungpook Natl Univ, Obstetr & Gynecol Dept, Chilgok Hosp, Daegu, South Korea |
|
|
[JCR상위 1.1%] A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04) | SCIE | 1.1 | ONCOLOGY | |||
|
Hong, Subeen (Hong, S) |
제1저자 | Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Seongnam Si, Kyonggi Do, South Korea |
|
|
[JCR상위 1.1%] Impacts of tocolytics on maternal and neonatal glucose levels in women with gestational diabetes mellitus | SCIE | 1.1 | OBSTETRICS & GYNECOLOGY |
페이지 이동: